Effective cytotoxicity mediated by a bispecific single-chain antibody directed against EpCAM/CD3 and cytokine-induced killer cells (CIK).

被引：0
|
作者：
Flieger, D
Kufer, P
Beier, I
Sauerbruch, T
Schmidt-Wolf, I
机构：
[1] Univ Bonn, Med Klin & Poliklin 1, D-53105 Bonn, Germany
[2] Univ Munich, LMU, Inst Immunol, D-80336 Munich, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
    Rettinger, E.
    Kuci, S.
    Kuci, Z.
    Weber, G.
    Willasch, A.
    Kreyenberg, H.
    Koehl, U.
    Von Laer, D.
    Fulda, S.
    Klingebiel, T.
    Bader, P.
    KLINISCHE PADIATRIE, 2011, 223 (01): : 52 - 52
  • [2] Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells
    Zhang, Lin
    Hou, Yanhong
    Zhang, Jian
    Hu, Jing
    Zhang, Kunpeng
    ONCOLOGY LETTERS, 2013, 5 (06) : 1826 - 1832
  • [3] Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3
    Baeuerle, Patrick A.
    Amann, Maria
    Brischwein, Klaus
    Lutterbuese, Petra
    Lorenczewski, Grit
    Krinner, Eva
    Kischel, Roman
    Lutterbuese, Ralf
    Kufer, Peter
    Schlereth, Bernd
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3613S - 3613S
  • [4] A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells
    Dimitri Flieger
    Peter Kufer
    Imke Beier
    Tilman Sauerbruch
    Ingo G. H. Schmidt-Wolf
    Cancer Immunology, Immunotherapy, 2000, 49 : 441 - 448
  • [5] A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon α and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells
    Flieger, D
    Kufer, P
    Beier, I
    Sauerbruch, T
    Schmidt-Wolf, IGH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (08) : 441 - 448
  • [6] CYTOTOXICITY OF CYTOKINE-INDUCED KILLER-CELLS COATED WITH BISPECIFIC ANTIBODY AGAINST ACUTE MYELOID-LEUKEMIA CELLS
    KANEKO, T
    FUSAUCH, Y
    KAKUI, Y
    OKUMURA, K
    MIZOGUCHI, H
    OSHIMI, K
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 219 - 229
  • [7] Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3
    Amann, Maria
    Brischwein, Klaus
    Lutterbuese, Petra
    Parr, Larissa
    Petersen, Laetitia
    Lorenczewski, Grit
    Krinner, Eva
    Bruckmeier, Sandra
    Lippold, Sandra
    Kischel, Roman
    Lutterbuese, Ralf
    Kufer, Peter
    Baeuerle, Patrick A.
    Schlereth, Bernd
    CANCER RESEARCH, 2008, 68 (01) : 143 - 151
  • [8] Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
    Vallera, Daniel A.
    Zhang, Bin
    Gleason, Michelle K.
    Oh, Seunguk
    Weiner, Louis M.
    Kaufman, Dan S.
    McCullar, Valarie
    Miller, Jeffrey S.
    Verneris, Michael R.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (04) : 274 - 282
  • [9] Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3 - Tumor cell-dependent T cell stimulation and cytotoxic activity
    Mack, M
    Gruber, R
    Schmidt, S
    Riethmuller, G
    Kufer, P
    JOURNAL OF IMMUNOLOGY, 1997, 158 (08): : 3965 - 3970
  • [10] Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells
    SchmidtWolf, GD
    Negrin, RS
    SchmidtWolf, IGH
    ANNALS OF HEMATOLOGY, 1997, 74 (02) : 51 - 56
12345